|
USP12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62636570877339E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.03081995664434E-12 |
| Normal-vs-Stage2 |
3.29040000002223E-06 |
| Normal-vs-Stage3 |
1.14079967694636E-10 |
| Normal-vs-Stage4 |
2.12860000003978E-06 |
| Stage1-vs-Stage2 |
4.203600E-01 |
| Stage1-vs-Stage3 |
9.655800E-01 |
| Stage1-vs-Stage4 |
8.482200E-01 |
| Stage2-vs-Stage3 |
4.433000E-01 |
| Stage2-vs-Stage4 |
5.273200E-01 |
| Stage3-vs-Stage4 |
8.591800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62470037423645E-12 |
| Normal-vs-AfricanAmerican |
2.28349994468857E-09 |
| Normal-vs-Asian |
2.10049999999073E-05 |
| Caucasian-vs-AfricanAmerican |
2.103600E-01 |
| Caucasian-vs-Asian |
6.924600E-01 |
| AfricanAmerican-vs-Asian |
4.631600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.4290999994504E-07 |
| Male-vs-Female |
1.176950E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.17559995072014E-09 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
5.73760039479509E-10 |
| Normal-vs-Extreme_Obese |
2.3957000000463E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.754960E-01 |
| Normal_Weight-vs-Obese |
3.824400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.842800E-01 |
| Extreme_Weight-vs-Obese |
2.515200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.345200E-01 |
| Obese-vs-Extreme_Obese |
4.601600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.23290000220555E-08 |
| Normal-vs-Age(41-60Yrs) |
2.72859512762125E-11 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
4.64729998927993E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.955200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.102800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.436800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.053500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.864570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.058600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
6.6019999467315E-09 |
| Normal-VS-KIRP CIMP |
7.617100E-04 |
| Normal-VS-Unclassified PRCC |
2.10959999999982E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.080200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.311900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.710500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.739400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.417400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.952600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.47024622979097E-13 |
| Normal-vs-N1 |
1.73909997513988E-09 |
| Normal-vs-N2 |
1.523660E-03 |
| N0-vs-N1 |
4.309600E-01 |
| N0-vs-N2 |
8.324400E-01 |
| N1-vs-N2 |
8.873600E-01 |
|
|
